Tag: Diagnosis

Reassessing colonoscopy surveillance: Early- vs average-onset colorectal cancer

Editor's Note Early-onset colorectal cancer (EO-CRC), diagnosed before age 50, is increasing in incidence worldwide. Despite existing postoperative colonoscopy surveillance strategies, the optimal intervals for EO-CRC patients are unclear due to limited long-term data. This study, titled “Early-onset Colorectal Cancer Patients Do Not Require Shorter Intervals for Post-surgical Surveillance Colonoscopy”…

Read More

By: Tarsilla Moura
June 26, 2024
Share

AI outperforms radiologists in detecting clinically significant prostate cancer

Editor's Note In a recent study, an artificial intelligence (AI) system detected more clinically significant prostate cancers and fewer indolent cancers than human radiologists reading MRIs, MedPage today reported June 13. The MedPage report covers a study published in Lancet Oncology that, according to researchers, “provided evidence that AI systems,…

Read More

By: Matt Danford
June 26, 2024
Share

The rise of AI in radiology—and what the future holds

When it comes to the adoption of artificial intelligence (AI) in medicine, radiology is leading the charge. As of May 13, 2024, the US Food and Drug Administration (FDA) had approved nearly 900 AI- and machine learning (ML)-enabled devices, and the vast majority of them are in radiology. One example…

Read More

By: Brita Belli
June 24, 2024
Share

AI analysis suggest breast cancer surgery “may do more harm than good” for middle-aged patients

Editor's Note Artificial intelligence (AI)-fueled analysis of electronic health records suggests that clinical guidelines for de-escalating surgery should be extended to younger breast cancer patients. Conducted by University of Pittsburgh and UPMC Hillman Cancer Center researchers and published in JCO Clinical Cancer Informatics, the analysis suggests that “surgery involving sentinel…

Read More

By: Matt Danford
June 6, 2024
Share

AI promises to eliminate unnecessary breast cancer biopsies

Editor's Note An AI model that outperformed MRI and ultrasound in identifying patients with axillary breast cancer metastasis shows the technology’s potential to reduce the need for needle or surgical biopsies, according to developers at UT Southwestern Medical Center. In a May 21 report on their new AI model, researchers…

Read More

By: Matt Danford
June 6, 2024
Share

Study reveals common symptoms, diagnosis delays in early-onset colorectal cancer

JAMA (healthcare publication) Network logo

Editor's Note A comprehensive systematic review and meta-analysis, published by JAMA Network on May 24 and encompassing 81 studies and over 24.9 million patients, shed light on the signs and symptoms associated with early-onset colorectal cancer (EOCRC) and highlighted significant delays in diagnosis. The analysis identified the most common presenting…

Read More

By: Tarsilla Moura
May 29, 2024
Share

Physician opinions on generative artificial intelligence reverse course, trend positive

Editor's Note Nearly 7 in 10 physicians responding to a recent Wolters Kluwer Health survey report that their views on the healthcare benefits of generative artificial intelligence (AI) have shifted in a positive direction during the past year. Detailed in an April 16 report, the survey also reveals that 40%…

Read More

By: Matt Danford
May 3, 2024
Share

FDA announces class 1 recall for disposable biopsy needle kit

Editor's Note Microscopic stainless steel debris on the insides of biopsy needles prompted the FDA to issue a class 1 recall—indicating risk of death or serious injury—for Elekta Instrument’s Disposable Biopsy Needle Kit, which is used with the Leksell Stereotactic System for brain tissue sampling during neurosurgery, the disposable biopsy…

Read More

By: Matt Danford
April 29, 2024
Share

FDA approves imaging drug for detecting cancer after lumpectomy

Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…

Read More

By: Matt Danford
April 22, 2024
Share

Unveiling ECRI’s 2024 Top 10 Patient Safety Concerns list

From integrating new technology to navigating shifts in care delivery and mitigating burnout, the most pressing challenges for healthcare organizations tend to be multifaceted problems that demand multifaceted solutions. For evidence of that, look no further than the Top 10 Patient Safety Concerns 2024 list from ECRI. For every risk…

Read More

By: Heather David, MSN, CRNP, AGACNP-BC, CSSYB
April 19, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat